Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 18, 2023
Fred Hutch hosts inaugural Dr. E. Donnall Thomas Symposium
Event draws leading researchers in transplantation, gene and cell therapy
Tip Sheet: Diversity in vaccine clinical trials, behind-the-scenes look at COVID-19 biostats, new cell therapy approved, plus meet ‘Megasphaera hutchinsoni’
Summaries of recent Fred Hutch research findings and other news
What's next for T-cell therapies: Q&A with Dr. Stanley Riddell
After approval of latest cellular therapy for non-Hodgkin lymphoma, the immunologist looks ahead
Fred Hutch Evergreen Fund awards six grants to promising projects
Scientists receive up to $200K to boost research for projects deemed to have partnership potential
Immunotherapy prevents relapse in small leukemia trial
Engineered T cells kept leukemia from returning in 12 high-risk patients
Learning more from T-cell therapy trials
Fred Hutch Immunotherapy Integrated Research Center awards grants to Drs. Brian Till, Cameron Turtle
New insights into CAR T-cell therapy's potential side effects
Detailed study of cytokine release syndrome and neurologic toxicities could help make emerging cancer immunotherapies safer